Leukemia Research Reports
Overview
Leukemia Research Reports is a scientific journal, published since 2012 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
Leuk Res Rep
Start
2012
End
Continuing
Frequency
Quarterly
e-ISSN
2213-0489
Country
United Kingdom
Language
English
Metrics
Metrics
h-index / Ranks: 13168
16
SJR / Ranks: 11868
299
CiteScore / Ranks: 12692
1.10
Recent Articles
1.
AbuGhannam S, Andonie C, Asbeh Y, Khalili A
Leuk Res Rep
. 2025 Mar;
23:100501.
PMID: 40061166
Multiple myeloma is a hematological malignancy that results from the proliferation of abnormal plasma cells, typically invading the bone marrow but occasionally involving other areas of the body. We present...
2.
Hong Z, Wang F
Leuk Res Rep
. 2025 Mar;
23:100505.
PMID: 40046494
Background: Atypical Chronic Myeloid Leukemia (aCML) is a rare and aggressive myelodysplastic syndrome/myeloproliferative neoplasm. This study aimed to provide a comprehensive understanding of the epidemiology, clinical characteristics, and survival outcomes...
3.
Hasegawa G, Nakagawa N, Ueda Y, Yamazaki M
Leuk Res Rep
. 2025 Feb;
23:100500.
PMID: 39896719
Brentuximab vedotin (BV) has demonstrated efficacy against CD30 peripheral T-cell lymphoma (PTCL). We herein report a case of CD30 peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) that emerged one month...
4.
Kawauchi K, Ogasawara T
Leuk Res Rep
. 2025 Jan;
23():100497.
PMID: 39845338
Primary effusion lymphoma (PEL)-like lymphoma is a rare variant of PEL that exhibits diverse clinical behaviors, ranging from mild to aggressive disease courses. The clinicopathological features and effective treatments for...
5.
Kim D, Sutamtewagul G, Yu Y
Leuk Res Rep
. 2025 Jan;
23():100494.
PMID: 39834628
Prognostication of acute myeloid leukemia (AML) at initial diagnosis relies on identification of pre-determined underlying genetic abnormalities. Nevertheless, the disease course of AML remains highly unpredictable and robust reliable prognostic...
6.
Bao X, Gong D, Zhou K, Huang W
Leuk Res Rep
. 2025 Jan;
23():100493.
PMID: 39811413
Abdominal multiple extramedullary plasmacytoma (EMP) is a rare disease. CD38-negative relapsed/refractory EMP after treatment with daratumumab has never been reported. In 2020, a patient with jaundice was diagnosed with plasmacytoma...
7.
Jamil A, Qureshi Z, El-Amir Z, Kupakuwana-Suk G, Akram H, Ahmad M, et al.
Leuk Res Rep
. 2025 Jan;
23():100495.
PMID: 39811412
Objective: This mini-review provides an overview of the current evidence for Revumenib, a first-in-class menin inhibitor, in treating AML with KMT2A rearrangements or NPM1 mutations. This therapy represents a promising...
8.
Chi W, Song J, Varisco T
Leuk Res Rep
. 2025 Jan;
23():100496.
PMID: 39811411
Multiple myeloma (MM) is a rare hematologic malignancy with a 5-year survival rate of 52 %. For transplant-eligible MM patients, high-dose chemotherapy followed by autologous stem cell transplant (ASCT) is...
9.
Da Silva Constante V, Couvert H, Wolfromm A, Ilzkovitz M
Leuk Res Rep
. 2025 Jan;
23():100498.
PMID: 39807111
We describe the case of a female patient with May-Hegglin syndrome who developed peripheral T-cell lymphoma not otherwise specified. The patient presents with systemic lupus erythematous phenotype and myelofibrosis secondary...
10.
Belmahi S, Kajeiou Z, Yacoubi L, Azzi N, Slaoui M, Berhili A, et al.
Leuk Res Rep
. 2024 Dec;
23:100488.
PMID: 39691507
Introduction: Acute promyelocytic leukemia (AML-M3), classified as acute Myeloid leukemia with PML RARA according to the 5th edition of the World Health Organization classification of haematolymphoid tumors 2022 [1], is...